- What is Somatuline Depot (lanreotide) Injection and how is it used?
- What are the most important side effects and other facts about Somatuline Depot (lanreotide)?
- Other side effects of Somatuline Depot (lanreotide)
- What is the dosage for Somatuline Depot (lanreotide)?
- Somatuline Depot (lanreotide) Contraindications, Pregnancy Safety and Drug Interactions
What is Somatuline Depot (lanreotide) Injection and how is it used?
Somatuline Depot is a prescription medicine used for:
- the long-term treatment of people with acromegaly when:
- surgery or radiotherapy have not worked well enough or
- they are not able to have surgery or radiotherapy
- the treatment of adults with a type of cancer known as neuroendocrine tumors, from the gastrointestinal tract or the pancreas (GEP-NETs) that has spread or cannot be removed by surgery.
- the treatment of adults with carcinoid syndrome to reduce the need for the use of short-acting somatostatin medicine.
What are the most important side effects and other facts about Somatuline Depot (lanreotide)?
The most common side effects of Somatuline Depot in people with carcinoid syndromeinclude:
Tell your healthcare provider right away if you have signs of an allergic reaction after receiving Somatuline Depot, including:
- swelling of your face, lips, mouth or tongue
- breathing problems
- fainting, dizziness, feeling lightheaded (low blood pressure)
- flushing or redness of your skin
These are not all the possible side effects of Somatuline Depot. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Other side effects of Somatuline Depot (lanreotide)
Somatuline Depot may cause serious side effects, including:
- Gallstones (cholelithiasis) and complications that can happen if you have gallstones. Gallstones are a serious but common side effect in people who take Somatuline Depot and have acromegaly and GEP-NET. Your healthcare provider may check your gallbladder before and during treatment with Somatuline Depot. Possible complications of gallstones include inflammation and infection of the gall bladder, and pancreatitis. Tell your healthcare provider if you get any symptoms of gallstones, including:
- Changes in your blood sugar (high blood sugaror low blood sugar). If you have diabetes, test your blood sugar as your healthcare provider tells you to. Your healthcare provider may change your dose of diabetes medicine especially when you first start receiving Somatuline Depot or if your dose of Somatuline Depot changes. High blood sugar is a common side effect in people with GEP-NET.
- Tell your healthcare provider right away if you have any signs or symptoms of high blood sugar or low blood sugar.
- Signs and symptoms of high blood sugar may include:
- Signs and symptoms of low blood sugar may include:
- Slow heart rate. Tell your healthcare provider right away if you have slowing of your heart rate or if you have symptoms of a slow heart rate, including:
- High blood pressure. High blood pressure can happen in people who receive Somatuline Depot and is a common side effect in people with GEP-NET.
- Changes in thyroid function. Somatuline Depot can cause the thyroid gland to not make enough thyroid hormones that the body needs (hypothyroidism) in people who have acromegaly. Tell your healthcare provider if you have signs and symptoms of low thyroid hormones levels, including:
The most common side effects of Somatuline Depot in people with acromegaly include:
The most common side effects of Somatuline Depot in people with GEP-NET include:
What is the dosage for Somatuline Depot (lanreotide)?
- You will receive a Somatuline Depot injection every 4 weeks in your healthcare provider's office
- Your healthcare provider may change your dose of Somatuline Depot or the length of time between your injections. Your healthcare provider will tell you how long you need to receive Somatuline Depot
- Somatuline Depot is injected deep under the skin of the upper outer area of your buttock. Your injection site should change (alternate) between your right and left buttock from one injection of Somatuline Depot to the next
- During your treatment with Somatuline Depot for acromegaly, your healthcare provider may do certain blood tests to see if Somatuline Depot is working.
Somatuline Depot (lanreotide) Contraindications, Pregnancy Safety and Drug Interactions
It is not known if Somatuline Depot is safe and effective in children.
Who should not receive Somatuline Depot?
Do not receive Somatuline Depot if you are allergic to lanreotide.
What should I tell my healthcare provider before receiving Somatuline Depot?
Before you receive Somatuline Depot, tell your healthcare provider about all of your medical conditions, including if you:
- have gallbladder problems
- have diabetes
- have heart problems
- have thyroid problems
- have kidney problems
- have liver problems
- are pregnant or plan to become pregnant. It is not known if Somatuline Depot will harm your unborn baby
- are breastfeeding or plan to breastfeed. It is not known if Somatuline Depot passes into your breast milk. You should not breastfeed if you receive Somatuline Depot and for 6 months after your last dose of Somatuline Depot
- are a female who can become pregnant. Somatuline Depot may affect fertility in females and may affect your ability to become pregnant. Talk to your healthcare provider if this is a concern for you.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Somatuline Depot and other medicines may affect each other, causing side effects. Somatuline Depot may affect the way other medicines work, and other medicines may affect how Somatuline Depot works. Your dose of Somatuline Depot or your other medicines may need to be changed.
Especially tell your healthcare provider if you take:
- insulin or other diabetes medicines
- cyclosporine (Gengraf, Neoral, or Sandimmune)
- medicines that lower your heart rate such as beta blockers
Latest Cancer News
Daily Health News
Somatuline Depot is a prescription medicine used for the long-term treatment of people with acromegaly when surgery or radiotherapy have not worked well enough or they are not able to have surgery or radiotherapy the treatment of adults with a type of cancer known as neuroendocrine tumors, from the gastrointestinal tract or the pancreas (GEP-NETs) that has spread or cannot be removed by surgery, the treatment of adults with carcinoid syndrome to reduce the need for the use of short-acting somatostatin medicine. Somatuline Depot can cause dizziness. If you have dizziness, do not drive a car or operate machinery.
Related Disease Conditions
Tumor grade is a system used to classify cancer cells in how likely the tumor is to grow and how abnormal they look under a microscope. Tumor grade is not the same as tumor stage. A biopsy is taken to determine if the tumor is benign (non cancerous) or malignant (cancerous).
Carcinoid Syndrome (Carcinoid Tumor)
A carcinoid tumor is a tumor that develops from enterochromaffin cells. The important characteristic of carcinoid tumors that sets them apart from other gastrointestinal tract tumors, is their potential to cause the carcinoid syndrome. Local symptoms may include: Abdominal pain Intestinal bleeding Flushing Gastrointestinal bleeding Diarrhea However, often symptoms of the carcinoid syndrome can be more devastating than the local symptoms. There are many options for the treatment of carcinoid tumors and carcinoid syndrome.
Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)
There are many types of pancreatic neuroendocrine tumors (NETs): gastrinoma, insulinoma, glucagonoma, VIPomas, and somatostatinomas. Symptoms and signs vary with the type of pancreatic NET. Standard treatments include surgery, chemotherapy, hormone therapy, chemoembolization, targeted therapy, and supportive care.
Treatment & Diagnosis
Medications & Supplements
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.